NRC Health

Hello everyone and welcome to the National Research Corporation second quarter 2022 earnings call. My name is Charlie and I'll be coordinating the call today. You will have the opportunity to ask a question at the end of the presentation. If you'd like to register a question, please press star followed by one on your telephone keypads. I want to hand over to your host, Mike Hayes, CEO to begin. Mike, please go ahead.

Thank you, Charlie, and welcome everyone to National Research Corporation's second quarter earnings call. My name is Mike Hayes, the company's CEO, and joining me on the call today is Kevin Karras, our Chief Financial Officer. Before we continue, I'd ask Kevin to review conditions related to any forward-looking statements that may be made as part of today's call. Kevin?

Thank you, Mike. This conference call includes forward-looking statements related to the company that involve risks and uncertainties that could cause actual results or outcomes to differ materially from those currently anticipated. These forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. For further information about the facts that could affect the company's future results, please see the company's filings with the Securities and Exchange Commission. With that, I'll turn it back to you, Mike.